Pharming Group N.V (PHAR) Net Income: 2020-2025
Historic Net Income for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to $90.2 million.
- Pharming Group N.V's Net Income rose 1255.41% to $90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.8 million, marking a year-over-year increase of 495.63%. This contributed to the annual value of -$12.0 million for FY2024, which is 283.16% down from last year.
- Per Pharming Group N.V's latest filing, its Net Income stood at $90.2 million for Q3 2025, which was up 856.29% from $9.4 million recorded in Q2 2025.
- Pharming Group N.V's 5-year Net Income high stood at $90.2 million for Q3 2025, and its period low was -$25.7 million during Q3 2021.
- Its 3-year average for Net Income is $5.1 million, with a median of $3.4 million in 2023.
- Per our database at Business Quant, Pharming Group N.V's Net Income surged by 29,235.91% in 2022 and then plummeted by 463.64% in 2023.
- Pharming Group N.V's Net Income (Quarterly) stood at $5.7 million in 2021, then tumbled by 132.35% to -$1.8 million in 2022, then surged by 375.83% to $5.1 million in 2023, then climbed by 28.20% to $6.5 million in 2024, then spiked by 1,255.41% to $90.2 million in 2025.
- Its last three reported values are $90.2 million in Q3 2025, $9.4 million for Q2 2025, and $6.5 million during Q4 2024.